AN ACT TO AMEND SECTION 97-32-51, MISSISSIPPI CODE OF 1972, TO DEFINE THE TERM "NICOTINE-ADJACENT PRODUCT" AND TO PROHIBIT THE SALE OF SUCH A PRODUCT TO AN INDIVIDUAL UNDER 21 YEARS OF AGE; TO AMEND SECTION 97-32-52, MISSISSIPPI CODE OF 1972, TO PROVIDE FOR ENHANCED PENALTIES FOR DISTRIBUTION OF NICOTINE-ADJACENT PRODUCTS WITHIN A CERTAIN PROXIMITY TO EDUCATIONAL PROPERTY OR OTHER PUBLIC PLACES; TO AMEND SECTION 75-102-1, MISSISSIPPI CODE OF 1972, TO REVISE THE DEFINITION OF "ENDS PRODUCT" TO INCLUDE NICOTINE-ADJACENT PRODUCTS; TO BRING FORWARD SECTION 75-102-2, MISSISSIPPI CODE OF 1972, FOR PURPOSES OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.

AN ACT TO ESTABLISH THE MISSISSIPPI HEALTHY MOMS, HEALTHY BABIES ACT OF 2026; TO SET FORTH LEGISLATIVE FINDINGS; TO ESTABLISH THE MISSISSIPPI INFANT MORTALITY REDUCTION INITIATIVE WITHIN THE MISSISSIPPI STATE DEPARTMENT OF HEALTH TO COORDINATE STATEWIDE EFFORTS TO REDUCE INFANT MORTALITY THROUGH EVIDENCE-BASED INTERVENTIONS; TO PROVIDE FOR EXPANDED ACCESS TO PRENATAL AND POSTPARTUM CARE AND TO EXPAND PUBLIC EDUCATION CAMPAIGNS; TO DIRECT THE DEPARTMENT TO EXPAND FUNDING OPPORTUNITIES FOR EVIDENCE-BASED HOME VISITING PROGRAMS; TO REQUIRE CERTAIN DATA COLLECTION AND REPORTING; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTION 23-15-801, MISSISSIPPI CODE OF 1972, TO AMEND DEFINITIONS RELATED TO THE CHAPTER OF CAMPAIGN FINANCE LAWS; TO AMEND SECTION 23-15-803, MISSISSIPPI CODE OF 1972, TO REQUIRE THAT A CANDIDATE OR POLITICAL COMMITTEE MUST FILE A STATEMENT OF ORGANIZATION BEFORE ACCEPTING ANY CONTRIBUTIONS; TO PROVIDE THE REQUIRED CONTENT OF THE STATEMENT OF ORGANIZATION; TO PROVIDE THAT THE SECRETARY OF STATE SHALL IMPOSE ADMINISTRATIVE PENALTIES AGAINST CANDIDATES AND POLITICAL COMMITTEES FOR FAILING TO COMPLY WITH THE REQUIREMENTS OF THIS CHAPTER; TO PROVIDE PENALTIES FOR FAILING TO COMPLY WITH THIS CHAPTER; TO PROVIDE THAT THE ATTORNEY GENERAL MAY PURSUE JUDICIAL ENFORCEMENT OF THE REQUIREMENTS OF THIS SECTION; TO AMEND SECTION 23-15-805, MISSISSIPPI CODE OF 1972, TO MODIFY THE CAMPAIGN FINANCE REPORTING PROCESS; TO REQUIRE THE SECRETARY OF STATE TO MAINTAIN A CENTRAL SITE ON THE INTERNET TO MAKE CAMPAIGN FINANCE REPORTS ACCESSIBLE TO THE PUBLIC AND EASILY SEARCHABLE; TO AMEND SECTION 23-15-807, MISSISSIPPI CODE OF 1972, TO AMEND THE INFORMATION AND REPORTING PROCESS AND TIMELINE THAT CANDIDATE COMMITTEES AND POLITICAL COMMITTEES MUST ADHERE TO IN REGARDS TO FILING REPORTS OF CONTRIBUTIONS AND DISBURSEMENTS; TO AMEND SECTION 23-15-809, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT INDIVIDUALS WHO FAIL TO PROVIDE THE REPORTS REQUIRED IN THIS SECTION SHALL BE SUBJECT TO PENALTY; TO AMEND SECTIONS 23-15-811 AND 23-15-813, MISSISSIPPI CODE OF 1972, TO CONFORM; TO AMEND SECTION 23-15-815, MISSISSIPPI CODE OF 1972, TO PROVIDE THE SECRETARY OF STATE WITH THE DUTY AND POWER TO OVERSEE THE FORMS AND PROCESSES DESCRIBED HEREIN; TO AMEND SECTION 23-15-817, MISSISSIPPI CODE OF 1972, TO CONFORM; TO AMEND SECTION 23-15-819, MISSISSIPPI CODE OF 1972, TO PROHIBIT FOREIGN NATIONALS FROM MAKING CAMPAIGN CONTRIBUTIONS IN CONNECTION WITH AN ELECTION FOR ANY CONSTITUTIONAL AMENDMENT, LOCAL BALLOT MEASURE, BALLOT REFERENDUM OR OTHER SIMILAR MEASURES; TO MAKE IT UNLAWFUL FOR A PERSON TO KNOWINGLY SOLICIT OR AID IN THE SOLICITATION OF CAMPAIGN CONTRIBUTIONS FROM FOREIGN NATIONALS; TO PROVIDE THAT THOSE FOUND GUILTY OF VIOLATING THIS SECTION SHALL BE SUBJECT TO FINES, IMPRISONMENT, OR BOTH, FOR SAID VIOLATION; TO ALLOW ANY PERSON WHO UNKNOWINGLY RECEIVES A CAMPAIGN CONTRIBUTION FROM A FOREIGN NATIONAL TO HAVE 30 DAYS TO REMIT THE VALUE OF THE UNLAWFUL CONTRIBUTION TO THE SECRETARY OF STATE ONCE THE VIOLATION HAS BEEN DETERMINED, OR BE SUBJECT TO PENALTIES; TO REQUIRE CANDIDATES AND CANDIDATE COMMITTEES TO PROVIDE GREATER TRANSPARENCY WHEN RECEIVING LOANS AND LINES OF CREDIT; TO REQUIRE THAT A CANDIDATE OR TREASURER OF A CANDIDATE COMMITTEE OR POLITICAL COMMITTEE KEEP DETAILED ACCOUNTS REGARDING CONTRIBUTIONS AND EXPENDITURES; TO REQUIRE THAT ALL ACCOUNT ACTIVITY BE KEPT CURRENT AND SHALL NOT LACK ENTRIES FOR ACTIVITY THAT TOOK PLACE LESS THAN TEN BUSINESS DAYS PRIOR; TO PROVIDE THAT ACCOUNTS MAY BE INSPECTED UNDER REASONABLE CIRCUMSTANCES AT ANY TIME BY THE SECRETARY OF STATE OR HIS OR HER AUTHORIZED REPRESENTATIVE; TO REQUIRE THAT ACCOUNT RECORDS SHALL BE PRESERVED FOR FOUR YEARS FROM THE DATE OF THE CONTRIBUTION, EXPENDITURE, GIFT, INVESTMENT OR LOAN; TO LIMIT POLITICAL CONTRIBUTIONS BY CORPORATIONS TO $1,000.00 PER CALENDAR YEAR; TO PROVIDE PENALTIES FOR VIOLATIONS OF CORPORATE POLITICAL CONTRIBUTION RESTRICTIONS; TO PROVIDE THAT THE ATTORNEY GENERAL MAY BRING FORTH ACTIONS FOR VIOLATIONS OF CORPORATE POLITICAL CONTRIBUTION RESTRICTIONS; TO AMEND SECTION 23-15-821, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT PERSONAL USE OF CAMPAIGN CONTRIBUTIONS BY A POLITICAL COMMITTEE IS PROHIBITED; TO PROHIBIT THE USE OF CAMPAIGN CONTRIBUTIONS TO PAY CIVIL PENALTIES INCURRED BY A POLITICAL COMMITTEE OR MEMBER THEREOF; TO REPEAL SECTIONS 97-13-15 AND 97-13-17, MISSISSIPPI CODE OF 1972, WHICH PROHIBITED POLITICAL CONTRIBUTIONS BY CORPORATIONS AND PENALIZED ILLEGAL CORPORATE CONTRIBUTIONS; AND FOR RELATED PURPOSES.

AN ACT TO BE KNOWN AS THE IBOGAINE DRUG DEVELOPMENT CLINICAL TRIAL ACT; TO AUTHORIZE THE ESTABLISHMENT OF A CONSORTIUM TO APPLY FOR SELECTION BY THE STATE DEPARTMENT OF HEALTH TO CONDUCT A DRUG DEVELOPMENT CLINICAL TRIAL WITH IBOGAINE AND SECURE THE UNITED STATES FOOD AND DRUG ADMINISTRATION'S (FDA) APPROVAL OF IBOGAINE AS A MEDICATION FOR THE TREATMENT OF OPIOID USE DISORDER, CO-OCCURRING SUBSTANCE USE DISORDER, AND ANY OTHER NEUROLOGICAL OR MENTAL HEALTH CONDITION FOR WHICH IBOGAINE DEMONSTRATES EFFICACY; TO REQUIRE THE CONSORTIUM TO SUBMIT TO THE DEPARTMENT A PROPOSAL FOR PURPOSES OF CONDUCTING AN IBOGAINE DRUG DEVELOPMENT CLINICAL TRIAL, AND SPECIFY WHAT THE PROPOSAL MUST INCLUDE; TO PROVIDE THAT AFTER SELECTING A CONSORTIUM, THE DEPARTMENT SHALL ENTER INTO AN INTERAGENCY CONTRACT WITH THE CONSORTIUM TO PROVIDE FUNDING TO IMPLEMENT THE CONSORTIUM'S PROPOSED IBOGAINE DRUG DEVELOPMENT CLINICAL TRIAL; TO SPECIFY WHAT THE INTERAGENCY CONTRACT MUST INCLUDE; TO PROVIDE THAT THE DEPARTMENT MAY NOT DISBURSE FUNDS TO OR FOR A SELECTED CONSORTIUM UNDER THE INTERAGENCY CONTRACT UNTIL THE CONSORTIUM RECEIVES AND THE DEPARTMENT VERIFIES THE RECEIPT OF MATCHING FUNDS FROM SOURCES OTHER THAN THE STATE; TO REQUIRE THE SELECTED CONSORTIUM TO SUBMIT AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH THE FDA AND SEEK A BREAKTHROUGH THERAPY DESIGNATION FOR IBOGAINE FROM THE FDA; TO REQUIRE THE SELECTED CONSORTIUM TO ENTER INTO AN AGREEMENT WITH A CONSORTIUM ESTABLISHED BY THE GOVERNMENT OF ANOTHER STATE THAT HAS SUBMITTED AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO THE FDA AND HAS REQUESTED A BREAKTHROUGH THERAPY DESIGNATION FOR IBOGAINE FROM THE FDA; TO REQUIRE THE SELECTED CONSORTIUM TO WORK WITH THE FDA TO COORDINATE THE DRUG DEVELOPMENT TRIAL IN MISSISSIPPI WITH IBOGAINE DRUG DEVELOPMENT TRIALS THAT ARE BEING CONDUCTED IN OTHER STATES; TO PROVIDE THAT ONLY AN INSTITUTION OF HIGHER LEARNING OR A HOSPITAL MAY SERVE AS A TRIAL SITE FOR CONDUCTING AN IBOGAINE DRUG DEVELOPMENT CLINICAL TRIAL; TO PROVIDE FOR ALLOCATION OF THE REVENUE ATTRIBUTABLE TO ALL INTELLECTUAL PROPERTY RIGHTS AND OTHER COMMERCIAL RIGHTS ARISING FROM THE DRUG DEVELOPMENT CLINICAL TRIAL CONDUCTED BY A CONSORTIUM DURING THE PERIOD FOR WHICH THE TRIAL IS FUNDED AND ANY FOLLOWING PERIOD OF COMMERCIALIZATION; TO PROVIDE THAT IF IBOGAINE IS APPROVED BY THE FDA TO TREAT A MEDICAL CONDITION, A PHYSICIAN WHO HAS PRESCRIBED IBOGAINE FOR A PATIENT SHALL SUPERVISE THE ADMINISTRATION OF IBOGAINE AT A HOSPITAL OR OTHER LICENSED HEALTH CARE FACILITY TO ENSURE THE PATIENT'S SAFETY WHILE THE PATIENT IS UNDER THE INFLUENCE OF IBOGAINE; AND FOR RELATED PURPOSES.

AN ACT TO CREATE THE MISSISSIPPI VETERANS PTSD IBOGAINE RESEARCH PILOT PROGRAM WITHIN THE STATE DEPARTMENT OF HEALTH TO SUPPORT LAWFUL CLINICAL RESEARCH INVOLVING IBOGAINE WITH VOLUNTEER MISSISSIPPI VETERANS DIAGNOSED WITH PTSD, SUBJECT TO STRICT SAFEGUARDS AND FULL COMPLIANCE WITH APPLICABLE STATE AND FEDERAL LAW; TO REQUIRE THE STATE DEPARTMENT OF HEALTH TO ADOPT AND DEVELOP A RESEARCH PROTOCOL; TO PROVIDE ELIGIBILITY REQUIREMENTS FOR PARTICIPANTS; TO REQUIRE THE STATE DEPARTMENT OF HEALTH TO PROVIDE AN ANNUAL REPORT TO THE LEGISLATURE; TO PROVIDE THAT THIS SECTION SHALL REPEAL BY OPERATION OF LAW ON JULY 1, 2028; TO AMEND SECTIONS 41-29-113 AND 41-29-115, MISSISSIPPI CODE OF 1972, TO RESCHEDULE IBOGAINE FROM SCHEDULE I TO SCHEDULE II OF THE UNIFORM CONTROLLED SUBSTANCES ACT; AND FOR RELATED PURPOSES.

AN ACT TO EXEMPT CERTAIN REGISTERED PROVIDERS OF SERVICES FOR HOMELESS PERSONS FROM CERTAIN FILING FEES AND LICENSURE APPLICATION FEES; TO AMEND SECTIONS 25-7-9 AND 63-1-43, MISSISSIPPI CODE OF 1972, TO CONFORM; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTION 43-11-1, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT PERSONAL CARE HOMES MUST BE LICENSED AND REGULATED BY THE STATE DEPARTMENT OF HEALTH IF THEY PROVIDE INDIVIDUAL OR GROUP LIVING ARRANGEMENTS FOR ONE OR MORE PERSONS WHO ARE UNRELATED TO THE OPERATOR; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTIONS 73-15-5 AND 73-15-20, MISSISSIPPI CODE OF 1972, TO AUTHORIZE CERTIFIED NURSE MIDWIVES TO PRACTICE AS AN ADVANCED PRACTICE REGISTERED NURSE WITHOUT HAVING A WRITTEN COLLABORATIVE/CONSULTATIVE RELATIONSHIP AGREEMENT WITH A PHYSICIAN OR HAVING AN AGREEMENT WITH A PHYSICIAN REGARDING THE PROTOCOL OR PRACTICE GUIDELINES OF THE CERTIFIED NURSE MIDWIFE; AND FOR RELATED PURPOSES.

AN ACT TO ENACT THE MISSISSIPPI PEDIATRIC ACCESS TO CRITICAL HEALTH CARE PROTECTION ACT; TO REQUIRE THE DIVISION OF MEDICAID TO MAKE PAYMENTS TO A BORDER CITY UNIVERSITY-AFFILIATED PEDIATRIC TEACHING HOSPITAL IF THE CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) APPROVE AN INCREASE IN THE ANNUAL REQUEST FOR THE PROVIDER PAYMENT INITIATIVE AUTHORIZED UNDER 42 CFR § 438.6(C) OR ANOTHER MEDICAID STATUTE OR REGULATION IN AN AMOUNT EQUAL TO OR GREATER THAN THE ESTIMATED ANNUAL PAYMENT TO BE MADE TO THE BORDER CITY UNIVERSITY-AFFILIATED PEDIATRIC TEACHING HOSPITAL; TO PROVIDE THAT NO PAYMENTS SHALL BE MADE UNDER THIS ACT UNTIL AFTER THE DIVISION OF MEDICAID HAS RECEIVED THE AMOUNT OF THE NON-FEDERAL SHARE OF SUCH PAYMENTS FROM A PUBLIC ENTITY CAPABLE OF FURNISHING AN INTERGOVERNMENTAL TRANSFER; TO PROVIDE THAT THE INTENT OF THE LEGISLATURE IS THAT THE COST OF PROVIDING SERVICES TO MISSISSIPPI MEDICAID BENEFICIARIES UNDER THE AGE OF TWENTY-ONE YEARS WHO ARE TREATED BY A BORDER CITY UNIVERSITY-AFFILIATED PEDIATRIC TEACHING HOSPITAL SHALL NOT EXCEED THE COST OF PROVIDING THE SAME SERVICES TO INDIVIDUALS IN HOSPITALS IN THE STATE, AND THAT SUCH PAYMENTS SHALL NOT RESULT IN ANY IN-STATE HOSPITAL RECEIVING PAYMENTS LOWER THAN THEY WOULD OTHERWISE RECEIVE IF NOT FOR THE PAYMENTS MADE TO ANY BORDER CITY UNIVERSITY-AFFILIATED PEDIATRIC TEACHING HOSPITAL; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTION 43-13-117, MISSISSIPPI CODE OF 1972, TO REQUIRE MEDICAID AND PRIVATE INSURANCE COMPANIES REGULATED BY THE STATE TO COVER ESSENTIAL DISABILITY-RELATED SUPPORTS FOR CHILDREN AND TO PRESCRIBE REQUIRED COVERED SERVICES; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTIONS 73-15-5 AND 73-15-20, MISSISSIPPI CODE OF 1972, TO AUTHORIZE A CERTIFIED NURSE MIDWIFE TO PRACTICE AS AN ADVANCED PRACTICE REGISTERED NURSE WITHOUT HAVING A WRITTEN COLLABORATIVE/CONSULTATIVE RELATIONSHIP AGREEMENT WITH A PHYSICIAN OR HAVING AN AGREEMENT WITH A PHYSICIAN REGARDING THE PROTOCOL OR PRACTICE GUIDELINES OF THE CERTIFIED NURSE MIDWIFE; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTION 73-25-33, MISSISSIPPI CODE OF 1972, TO REVISE THE MEANING OF "PRACTICE OF MEDICINE" TO INCLUDE THE PRACTICE OF OBESITY MEDICINE; TO AMEND SECTION 73-25-34, MISSISSIPPI CODE OF 1972, TO REVISE THE MEANING OF "TELEMEDICINE" TO INCLUDE THE PRACTICE OF MEDICINE BY A LICENSED PHYSICIAN AT A DISTANT SITE TO A PATIENT LOCATED AT AN ORIGINATING SITE, USING HIPAA-COMPLIANT TELECOMMUNICATION SYSTEMS, INCLUDING SYNCHRONOUS OR ASYNCHRONOUS ELECTRONIC AND COMMUNICATION TECHNOLOGIES, REMOTE MONITORING TECHNOLOGIES AND STORE-AND-FORWARD TRANSFER TECHNOLOGY; TO AMEND SECTION 41-29-139, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT A PHYSICIAN PRACTICING OBESITY MEDICINE MAY PRESCRIBE A LEGEND DRUG, INCLUDING GLP-1 THERAPEUTICS, TO A PATIENT VIA TELEMEDICINE SUBJECT TO CERTAIN CONDITIONS; TO REQUIRE THE MISSISSIPPI STATE BOARD OF MEDICAL LICENSURE TO ADOPT, AMEND OR REPEAL RULES AS NECESSARY TO IMPLEMENT THIS ACT WITHIN 180 DAYS AFTER THE EFFECTIVE DATE OF THIS ACT; AND FOR RELATED PURPOSES.

AN ACT TO AUTHORIZE A PHARMACIST TO TEST OR SCREEN FOR AND INITIATE OR ADMINISTER TREATMENT FOR MINOR, NONCHRONIC HEALTH CONDITIONS; TO DEFINE THE TERM "MINOR, NONCHRONIC HEALTH CONDITION"; TO AUTHORIZE A PHARMACIST TO DELEGATE THE ADMINISTRATIVE AND TECHNICAL TASKS OF PERFORMING CERTAIN TESTS TO AN INTERN OR PHARMACY TECHNICIAN ACTING UNDER THE SUPERVISION OF THE PHARMACIST; TO AUTHORIZE A PHARMACIST TO PROHIBIT THE DENIAL OF REIMBURSEMENT UNDER HEALTH BENEFIT PLANS FOR SERVICES AND PROCEDURES PERFORMED BY A PHARMACIST THAT ARE WITHIN THE SCOPE OF THE PHARMACIST'S LICENSE, AND WOULD BE COVERED IF THE SERVICES OR PROCEDURES WERE PERFORMED BY A PHYSICIAN, AN ADVANCED PRACTICE REGISTERED NURSE, OR A PHYSICIAN ASSISTANT; TO AMEND SECTION 73-21-73, MISSISSIPPI CODE OF 1972, TO INCLUDE IN THE DEFINITION OF THE TERM "PRACTICE OF PHARMACY", ORDERING, PERFORMING AND INTERPRETING CERTAIN TESTS AND INITIATING, ADMINISTERING OR MODIFYING DRUG THERAPY; TO BRING FORWARD SECTION 83-9-36, MISSISSIPPI CODE OF 1972, WHICH RELATES TO PRESCRIBING PRACTITIONERS, STEP THERAPY OR FAIL-FIRST PROTOCOLS AND OVERRIDE PROCEDURES, FOR THE PURPOSE OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.

AN ACT TO AMEND SECTION 41-7-191, MISSISSIPPI CODE OF 1972, TO AUTHORIZE THE STATE DEPARTMENT OF HEALTH TO ISSUE A CERTIFICATE OF NEED TO A NONPROFIT COMPANY BASED IN JEFFERSON COUNTY THAT PREVIOUSLY HAD A CERTIFICATE OF NEED TO PROVIDE HOME HEALTH SERVICES BEFORE THE HOME HEALTH MORATORIUM WAS ENACTED, TO PROVIDE HOME HEALTH SERVICES IN ADAMS, AMITE, FRANKLIN, JEFFERSON AND WILKINSON COUNTIES; AND FOR RELATED PURPOSES.

AN ACT TO AUTHORIZE THE SALE AND PURCHASE OF IVERMECTIN SUITABLE FOR HUMAN USE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTH CARE PROFESSIONAL; AND FOR RELATED PURPOSES.